Prediction of α1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 7, 2007, Pages 1237-1241

  Yamada, Shizuo ^a   Kato, Yasuhiro ^a   Okura, Takashi ^a   Kagawa, Yoshiyuki ^a   Kawabe, Kazuki ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b TOKYO TEISHIN HOSPITAL   (Japan)

Author keywords

1 adrenoceptor occupancy; Prostate; Silodosin; Tamsulosin; Terazosin

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; PRAZOSIN; SILODOSIN; TAMSULOSIN; TERAZOSIN; TRITIUM; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; INDOLE DERIVATIVE; SULFONAMIDE; TERAZOSINE; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NONHUMAN; NORMAL HUMAN; PROSTATE HYPERTROPHY; RAT; RECEPTOR OCCUPANCY; URINARY TRACT OBSTRUCTION; ANIMAL; BLOOD; METABOLISM; PROSTATE; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; ANIMALS; HUMANS; INDOLES; MALE; PRAZOSIN; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; SULFONAMIDES;

EID: 34447132198     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1237     Document Type: Article

References (20)

1. Yamada Y., Matsuyama K., Ito K., Sawada Y., Iga T., J. Pharmacokinet. Biopharm., 23, 463-478 (1995).
2. Yamada Y., Shibuya F., Hamada J., Sawada Y., Iga T., J. Pharmacokinet. Biopharm., 23, 131-145 (1995).
3. Yasuda S. U., Wellstein A., Likhari P., Barbey J. T., Woosley R. L., Clin. Pharmacol. Ther., 58, 210-220 (1995).
4. Haraguchi K., Ito K., Kotaki H., Sawada Y., Iga T., Drug Metab. Dispos., 25, 675-684 (1997).
5. Yamada S., Suzuki M., Kato Y., Kimura R., Mori R., Matsumoto K., Maruyama M., Kawabe K., Life Sci., 50, 127-135 (1992).
6. Kawabe K., Moriyama N., Yamada S., Taniguchi N., Int. J. Urol., 1, 203-211 (1994).
7. Rossi C., Kortmann B. B., Sonke G. S., Floratos D. L., Kiemeney L. A., Wijkstra H., de la Rosette J. J., J. Urol., 165, 38-41 (2001).
8. Shibata K., Foglar R., Horie K., Obika K., Sakamoto A., Ogawa S., Tsujimoto G., Mol. Pharmacol., 48, 250-258 (1995).
9. Moriyama N., Akiyama K., Murata S., Taniguchi J., Ishida N., Yamazaki S., Kawabe K., Eur. J. Pharmacol., 331, 39-42 (1997).
10. Akiyama K., Hora M., Tatemichi S., Masuda N., Nakamura S., Yamagishi R., Kitazawa M., J. Pharmacol. Exp. Ther., 291, 81-91 (1999).
11. Yamada S., Okura T., Kimura R., J. Pharmacol. Exp. Ther., 296, 160-167 (2001).
12. Yamada S., Ashizawa N., Ushijima H., Nakayama K., Hayashi E., Honda K., J. Pharmacol. Exp. Ther., 242, 326-330 (1987).
13. Yamada S., Ohkura T., Deguchi Y., Kimura R., J. Pharmacol. Exp. Ther., 289, 1575-1583 (1999).
14. Yamada S., Yamamura H. I., Roeske W. R., J. Pharmacol. Exp. Ther., 215, 176-185 (1980).
15. Yamaoka K., Tanaka H., Okumura K., Yasuhara M., Hori R., J. Pharmacobio-Dyn., 8, 246-256 (1985).
16. Koiso K., Akaza H., Kikuchi K., Aoyagi K., Ohba S., Miyazaki M., Ito M., Sueyoshi T., Matsushima H., Kamimura H., Watanabe T., Higuchi S., J. Clin. Pharmacol., 36, 1029-1038 (1996).
17. Ebihara A., Kondo K., Ohashi K., J. Clin. Ther. Med., 3, 667-679 (1987) (in Japanese).
18. Yamada S., Suzuki M., Tanaka C., Mori R., Kimura R., Inagaki O., Honda K., Asano M., Takenaka T., Kawabe K., Clin. Exp. Pharmacol. Physiol., 21, 405-411 (1994).
19. Yamada S., Tanaka C., Ohkura T., Mori R., Kimura R., Inagaki O., Honda K., Kawabe K., Urol. Res., 22, 273-278 (1994).
20. Ohkura T., Yamada S., Deguchi Y., Kimura R., Matsushima H., Higuchi S., Inagaki O., Honda K., Takenaka T., Life Sci., 63, 2147-2155 (1998).